Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Surg Endosc ; 12(1): 73-5, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9419310

RESUMEN

Laparoscopic splenectomy has been safely performed for small spleens, but technical limitations have prevented massive splenectomy. We describe a technique of early hilar devascularization to enable massive splenectomy in three patients over the age of 80 years. Massive splenectomy was performed with minimal blood loss and minor morbidity. Early laparoscopic control of the splenic artery and vein will enable the safe removal of the massive spleen, without major laparotomy. Morbidity of splenectomy may be reduced by laparoscopy.


Asunto(s)
Laparoscopía/métodos , Esplenectomía/métodos , Arteria Esplénica/cirugía , Vena Esplénica/cirugía , Esplenomegalia/cirugía , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino
2.
Clin Pharmacol Ther ; 47(3): 331-7, 1990 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2311334

RESUMEN

We examined the pharmacokinetics of a transdermal nicotine patch and evaluated the usefulness of such a patch in a pilot smoking-cessation program. Use of the patch was associated with plasma nicotine concentrations that were comparable to smoking or to the use of other smoking-cessation devices. However, these plasma concentrations were maintained for 24 hours, and the patch appeared to be suitable for use once a day. Its use in a 6-week placebo-controlled double-blind study resulted in a significant degree of smoking cessation or in reduction of smoking activity. The findings suggest that it may be valuable to extend investigations to a larger population and that transdermal nicotine may have a useful role in smoking-cessation therapy.


Asunto(s)
Nicotina/farmacocinética , Prevención del Hábito de Fumar , Tabaquismo/psicología , Administración Cutánea , Adulto , Humanos , Masculino , Nicotina/administración & dosificación , Nicotina/sangre , Proyectos Piloto , Tabaquismo/metabolismo
3.
J Pharm Pharmacol ; 38(9): 638-42, 1986 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-2877061

RESUMEN

The dissolution of cholesterol monohydrate and calcium bilirubinate (neutral salt) mixtures in monooctanoin was investigated using the static disc method. The intrinsic dissolution rate of calcium bilirubinate was orders of magnitude (approximately 1000 fold) lower than that of cholesterol. Cholesterol release decreased as its weight fraction in the solid decreased. In model systems containing below 50% cholesterol dissolution became negligible. The release profiles deviated from the classical model for dissolution from two component mixtures. The observed dissolution profiles of both components were greater than predicted by theory. Anomalous positive curvatures in dissolution profiles suggested that calcium bilirubinate initially reduced the surface area available for cholesterol dissolution. A model, taking into account the change in surface area, was used to fit the cholesterol dissolution data. The results were consistent with the reported relationship between human gallbladder stone cholesterol content and average stone weight loss.


Asunto(s)
Bilirrubina/análisis , Colesterol/análisis , Glicéridos/análisis , Caprilatos , Fenómenos Químicos , Química Física , Solubilidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA